CNWCX
Price
$76.39
Change
-$1.75 (-2.24%)
Updated
Dec 18 closing price
FNWFX
Price
$80.67
Change
-$1.85 (-2.24%)
Updated
Dec 18 closing price
Ad is loading...

CNWCX vs FNWFX

Header iconCNWCX vs FNWFX Comparison
Open Charts CNWCX vs FNWFXBanner chart's image
American Funds New World 529C
Price$76.39
Change-$1.75 (-2.24%)
VolumeN/A
CapitalizationN/A
American Funds New World F3
Price$80.67
Change-$1.85 (-2.24%)
VolumeN/A
CapitalizationN/A
CNWCX vs FNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CNWCX vs. FNWFX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNWCX is a Buy and FNWFX is a Buy.

FUNDAMENTALS
Fundamentals
CNWCX (64B) and FNWFX (64B) have equal amount of cash in the bank . FNWFX pays higher dividends than CNWCX: FNWFX (1.56) vs CNWCX (0.33). CNWCX was incepted earlier than FNWFX: CNWCX (23 years) vs FNWFX (8 years). CNWCX (32.00) and FNWFX (32.00) have comparable annual turnover. CNWCX has a lower initial minimum investment than FNWFX: CNWCX (250) vs FNWFX (1000000). FNWFX annual gain was more profitable for investors over the last year : 12.00 vs. CNWCX (10.68). FNWFX return over 5 years is better than : 16.03 vs. CNWCX (12.16).
CNWCXFNWFXCNWCX / FNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years8 years-
Gain YTD8.76910.02787%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRA250N/A-
Net Assets64B64B100%
Annual Yield % from dividends0.331.5621%
Returns for 1 year10.6812.0089%
Returns for 3 years-1.650.71-232%
Returns for 5 years12.1616.0376%
Returns for 10 years43.59N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRC75.93-0.76
-0.99%
Brady Corp
GEN29.38-0.35
-1.18%
Gen Digital
SACH1.24-0.03
-2.36%
Sachem Capital Corp
NN17.55-0.45
-2.50%
NextNav
CANF1.42-0.09
-5.96%
Can-Fite BioPharma Ltd